LIDOCAINE HCI
LIDOCAINE HCI JELLY, USP, 2%, 100mg URO-JET
Approved
Approval ID
95351883-ec37-f94a-e053-2995a90aa36a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 25, 2024
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LIDOCAINE HCI
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1389
Application NumberANDA086283
Product Classification
M
Marketing Category
C73584
G
Generic Name
LIDOCAINE HCI
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 25, 2024
FDA Product Classification
INGREDIENTS (1)
LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR